ASX - Delayed Quote AUD

AFT Pharmaceuticals Limited (AFP.AX)

2.5500
0.0000
(0.00%)
As of 1:04:23 PM GMT+10. Market Open.

Key Executives

Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in AUD.
NameTitlePayExercisedYear Born
Dr. Hartley Atkinson Ph.D. Co-Founder, CEO, MD & Executive Director 895.4k -- --
Ms. Marree Atkinson Co-Founder, Chief of Staff & Executive Director 161.15k -- --
Mr. Malcolm Tubby B.A., BA(Hon's), ICAEW, ICANZ CFO & Company Secretary -- -- --
Ms. Ioana Stanescu Chief Scientific Officer -- -- --
Mr. Murray Keith Group Marketing Manager -- -- --

AFT Pharmaceuticals Limited

129 Hurstmere Road
Level 1 Takapuna
Auckland, 0622
New Zealand
64 9 488 0232 https://www.aftpharm.com
Sector: 
Healthcare
Full Time Employees: 
110

Description

AFT Pharmaceuticals Limited, together with its subsidiaries, engages in the development and sale of pharmaceutical products in New Zealand, Australia, Asia, and internationally. It offers products for use in the areas of allergy, gastrointestinal, cold and flu, digestive health, eye care, first aid, nail care, oral care, pain management, skin care, vitamins, and supplements, as well as other products. The company has collaboration with Belgium's Hyloris Pharmaceuticals to develop a novel innovative injectable iron deficiency therapy. AFT Pharmaceuticals Limited was incorporated in 1997 and is headquartered in Auckland, New Zealand.

Corporate Governance

AFT Pharmaceuticals Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

May 21, 2025 at 8:30 PM UTC

AFT Pharmaceuticals Limited Earnings Date

Recent Events

June 19, 2024 at 12:00 AM UTC

Ex-Dividend Date

Related Tickers